LNSR
Lensar·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 3
Stock Price Surged Significantly
Significant Net Income Decline
Revenue Beats Expectation
Hanging Man
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LNSR
Lensar, Inc.
A global medical technology company that advancing femtosecond laser surgical solutions for the treatment of cataracts
Healthcare Equipment and Supplies
08/20/2004
10/02/2020
NASDAQ Stock Exchange
140
12-31
Common stock
2800 Discovery Drive
, Orlando
, Florida 32826
--
Lensar, Inc., was incorporated in Delaware on August 20, 2004. The Company is a commercial-stage medical device company focused on the design, development and sale of advanced femtosecond laser systems for the treatment of cataracts and for the treatment of pre-existing or surgically induced corneal astigmatism.
Company Financials
EPS
LNSR has released its 2025 Q3 earnings. EPS was reported at -0.31, versus the expected -0.08, missing expectations. The chart below visualizes how LNSR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LNSR has released its 2025 Q3 earnings report, with revenue of 14.32M, reflecting a YoY change of 5.74%, and net profit of -3.71M, showing a YoY change of -147.20%. The Sankey diagram below clearly presents LNSR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
